未登录 分享 收藏
分享 收藏
分享 收藏
分享 收藏
An Indirect Comparison of Elranatamab's Progression-Free Survival, Duration of Response, and Overall Survival from MagnetisMM-3 Versus Real-World External Control Arms in Triple-Class Refractory Multiple Myeloma Elranatamab在MagnetisMM-3研究中的无进展生存期、缓解持续时间与总体生存期的间接比较，以及其在三药难治性多发性骨髓瘤中的真实世界外部对照组比较。 Costa, Luciano J.; Leblanc, Thomas W.; Tesch, Hans; Sonneveld, Pieter; Johnson, Sarasa M. A.; Vekeman, Francis; Hlavacek, Patrick; Meche, Aster; Cislo, Paul; Hughes, David; Nador, Guido; Dibonaventura, Marco 分享 收藏
Elranatamab efficacy in MagnetisMM-3 compared with real-world control arms in triple-class refractory multiple myeloma Costa, Luciano J.; LeBlanc, Thomas W.; Tesch, Hans; Sonneveld, Pieter; Kyle, Ryan P.; Sinyavskaya, Liliya; Hlavacek, Patrick; Meche, Aster; Ren, Jinma; Schepart, Alex; Aydin, Didem; Nador, Guido; DiBonaventura, Marco daCosta 分享 收藏
Interpreting the Relationship Among Itch, Sleep, and Work Productivity in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-2 Yosipovitch, Gil; Gooderham, Melinda J.; Staender, Sonja; Fonacier, Luz; Szepietowski, Jacek C.; Deleuran, Mette; Girolomoni, Giampiero; Su, John C.; Bushmakin, Andrew G.; Cappelleri, Joseph C.; Feeney, Claire; Chan, Gary; Thorpe, Andrew J.; Valdez, Hernan; Biswas, Pinaki; Rojo, Ricardo; Dibonaventura, Marco; Myers, Daniela E. 分享 收藏
Abrocitinib effect on patient-reported outcomes in patients with moderate-to-severe atopic dermatitis: Results from phase 3 studies, including the long-term extension JADE EXTEND study Reich, K.; Silverberg, J. I.; Papp, K. A.; Deleuran, M.; Katoh, N.; Strober, B.; Beck, L. A.; de Bruin-Weller, M.; Werfel, T.; Zhang, F.; Biswas, P.; DiBonaventura, M. D.; Chan, G.; Farooqui, S. A.; Kerkmann, U.; Clibborn, C. 分享 收藏
Abrocitinib efficacy and safety in patients with moderate-to-severe atopic dermatitis: Results from phase 3 studies, including the long-term extension JADE EXTEND study Reich, Kristian; Silverberg, Jonathan I.; Papp, Kim A.; Deleuran, Mette; Katoh, Norito; Strober, Bruce; Beck, Lisa A.; de Bruin-Weller, Marjolein; Werfel, Thomas; Zhang, Fan; Biswas, Pinaki; DiBonaventura, Marco D.; Chan, Gary; Johnson, Susan; Farooqui, Saleem A.; Kerkmann, Urs; Clibborn, Claire 分享 收藏
Efficacy and Safety of Abrocitinib in Patients with Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post Hoc Analysis of the Randomized Phase 3 JADE COMPARE Trial Simpson, Eric L.; Silverberg, Jonathan I.; Thyssen, Jacob P.; Viguier, Manuelle; Thaci, Diamant; de Bruin-Weller, Marjolein; Weidinger, Stephan; Chan, Gary; DiBonaventura, Marco; Biswas, Pinaki; Feeney, Claire; Koulias, Christopher; Cork, Michael J. 分享 收藏
分享 收藏
Early Itch Response with Abrocitinib Is Associated with Later Efficacy Outcomes in Patients with Moderate-to-Severe Atopic Dermatitis: Subgroup Analysis of the Randomized Phase III JADE COMPARE Trial Staender, Sonja; Kwatra, Shawn G.; Silverberg, Jonathan, I; Simpson, Eric L.; Thyssen, Jacob P.; Yosipovitch, Gil; Zhang, Fan; Cameron, Michael C.; Cella, Ricardo Rojo; Valdez, Hernan; DiBonaventura, Marco; Feeney, Claire 分享 收藏
Magnitude and Time Course of Response to Abrocitinib for Moderate-to-Severe Atopic Dermatitis Reich, Kristian; Lio, Peter A.; Bissonnette, Robert; Alexis, Andrew F.; Lebwohl, Mark G.; Pink, Andrew E.; Kabashima, Kenji; Boguniewicz, Mark; Nowicki, Roman J.; Valdez, Hernan; Zhang, Fan; DiBonaventura, Marco; Cameron, Michael C.; Clibborn, Claire 分享 收藏
Patient perspectives of atopic dermatitis: comparative analysis of terminology in social media and scientific literature, identified by a systematic literature review Silverberg, J., I; Feldman, S. R.; Begolka, W. Smith; Johnson, M. B.; Stanojev, C.; DiBonaventura, M.; Cella, R. Rojo; Valdez, H.; Feeney, C.; Thyssen, J. P. 分享 收藏
Real-World Effectiveness of Newly Initiated Systemic Therapy for Atopic Dermatitis in the United States: A Claims Database Analysis Wu, Jashin J.; Lafeuille, Marie-Helene; Emond, Bruno; Fakih, Iman; Duh, Mei Sheng; Cappelleri, Joseph C.; Yin, Natalie; Feeney, Claire; Myers, Daniela E.; DiBonaventura, Marco 分享 收藏
High threshold efficacy responses in moderate-to-severe atopic dermatitis are associated with additional quality of life benefits: pooled analyses of abrocitinib monotherapy studies in adults and adolescents Stander, S.; Bhatia, N.; Gooderham, M. J.; Silverberg, J., I; Thyssen, J. P.; Biswas, P.; DiBonaventura, M.; Romero, W.; Farooqui, S. A. 分享 收藏
Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate-to-severe atopic dermatitis: Results from the JAK1 Atopic Dermatitis Efficacy and Safety (JADE) REGIMEN phase 3 trial Blauvelt, Andrew; Silverberg, Jonathan, I; Lynde, Charles W.; Bieber, Thomas; Eisman, Samantha; Zdybski, Jacek; Gubelin, Walter; Simpson, Eric L.; Valenzuela, Fernando; Criado, Paulo Ricardo; Lebwohl, Mark G.; Feeney, Claire; Khan, Tahira; Biswas, Pinaki; DiBonaventura, Marco; Valdez, Hernan; Cameron, Michael C.; Rojo, Ricardo 分享 收藏
Patient-reported outcomes from the JADE COMPARE randomized phase 3 study of abrocitinib in adults with moderate-to-severe atopic dermatitis Thyssen, J. P.; Yosipovitch, G.; Paul, C.; Kwatra, S. G.; Chu, C. Y.; DiBonaventura, M.; Feeney, C.; Zhang, F.; Myers, D.; Rojo, R.; Valdez, H. 分享 收藏
Impact of oral abrocitinib on signs, symptoms and quality of life among adolescents with moderate-to-severe atopic dermatitis: an analysis of patient-reported outcomes Cork, M. J.; McMichael, A.; Teng, J.; Valdez, H.; Rojo, R.; Chan, G.; Zhang, F.; Myers, D. E.; DiBonaventura, M. 分享 收藏
Efficacy and Safety of Abrocitinib in Combination With Topical Therapy in Adolescents With Moderate-to-Severe Atopic Dermatitis The JADE TEEN Randomized Clinical Trial Eichenfield, Lawrence F.; Flohr, Carsten; Sidbury, Robert; Siegfried, Elaine; Szalai, Zsuzsanna; Galus, Ryszard; Yao, Zhirong; Takahashi, Hidetoshi; Barbarot, Sebastien; Feeney, Claire; Zhang, Fan; DiBonaventura, Marco; Rojo, Ricardo; Valdez, Hernan; Chan, Gary 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png)
BLOOD.png)
.png){kind=icon}
分享.png){kind=icon}
收藏